Skip to main content
VCbacked
Log inGet Started

Lakefield Veterinary Group

Kent, United States

Lakefield Veterinary Group is a veterinary company that specializes in preserving the independence and local legacy for veterinarians.

$105.0M raised
Jul 2024
Private Equity
Health CarePetWellness

Top Investors

Peloton Capital Management

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lakefield Veterinary Group

How much funding has Lakefield Veterinary Group raised?
Lakefield Veterinary Group has raised $105.0M in total funding. The most recent round was Private Equity. The last funding was announced in July 2024.
Who are Lakefield Veterinary Group's investors?
Lakefield Veterinary Group's investors include Peloton Capital Management.
Where is Lakefield Veterinary Group headquartered?
Lakefield Veterinary Group is headquartered in Kent, United States.
What does Lakefield Veterinary Group do?
Lakefield Veterinary Group is a veterinary company that specializes in preserving the independence and local legacy for veterinarians.
What stage is Lakefield Veterinary Group at?
Lakefield Veterinary Group is at the Private Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lakefield Veterinary Group — Funding & Investors." VCBacked, July 15, 2024, https://www.vcbacked.co/company/lakefield-veterinary-group. Accessed July 2, 2026.
APA
VCBacked. (2024). Lakefield Veterinary Group — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lakefield-veterinary-group
Wikipedia (cite web)
{{cite web |title=Lakefield Veterinary Group — Funding & Investors |url=https://www.vcbacked.co/company/lakefield-veterinary-group |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
OncoRevive
Brunswick$119K
Rapport Therapeutics
Boston$250.0M
YLAH
Bern$589K
Novostia
Epalinges$6.6M